ABSTRACT OBJECTIVES: Following implementation of a publicly funded rotavirus immunization program in Quebec (Canada) in 2011, its impact on gastroenteritis hospitalization rates, a proxy for severe gastroenteritis, was assessed.
R otavirus is the main cause of acute gastroenteritis (AGE) among children under five years of age worldwide. 1 In developed countries, hospitalizations related to rotavirus gastroenteritis (RVGE) generate important costs for society. 2 Before the arrival of rotavirus vaccines in Canada, there were on average 7,500 to 10,500 estimated hospitalizations for RVGE annually. 3, 4 Rotavirus infections were responsible for up to 72% of AGE hospitalizations during winter months. 5 Rotavirus season started in December and ended in May, with a peak incidence observed in March and April. 4 In Canada, two rotavirus vaccines, RotaTeq ® and Rotarix ® , were approved in 2006 and 2007, and were recommended by the National Advisory Committee on Immunization in July 2010 to prevent RVGE in young children. 6 Both vaccines showed high clinical efficacy in upper-middle and high-income countries, reducing RVGE hospitalizations by 85%-100%. 7, 8 On November 1, 2011, the monovalent rotavirus vaccine Rotarix ® (RV1), offered to all infants in two doses and administered orally at two and four months of age, was introduced into the publicly funded vaccination program in Quebec. This program primarily aims at reducing gastroenteritis morbidity in the general population, including vulnerable subgroups.
After implementation of rotavirus vaccination programs, many studies from the US, Australia and the European Union documented significant declines in AGE and RVGE hospitalization rates. [9] [10] [11] Globally, they observed a 30%-60% decline in AGE hospitalization rates. Only two studies from Mexico analyzed relative reductions according to socio-economic status. 12, 13 They found lower, but still significant, reductions in diarrhea-related hospitalizations and deaths in states with low socio-economic status. To date, no studies have assessed the impact of the rotavirus immunization program in Quebec since its implementation in 2011. In Canada, where people benefit from the universal health care system, an impact study could be highly relevant in describing the burden of severe rotavirus infections over time, before and after implementation of universal rotavirus immunization, and could therefore assess its public health benefits in the general population as well as in socio-economic subgroups.
The aim of this study was to assess the impact of the rotavirus routine immunization program on gastroenteritis morbidity and health inequalities among young children living in the Eastern Townships (QC, Canada). More specifically, AGE and RVGE hospitalization rates in post-program years were compared with those of the pre-program years, overall and according to individualand neighbourhood-level socio-economic characteristics. Rotavirus vaccine coverage was also examined in the post-program period overall and according to the same characteristics.
METHODS

Study setting
The Eastern Townships, a southern region of Quebec with 320,000 residents in 2014 (4% of the Quebec population), is composed of a mix of urban, semi-urban and rural communities.
14 One central city, named Sherbrooke (Quebec's sixth largest city), has half of the regional population. This city contains one central tertiary hospital, the Centre hospitalier universitaire de Sherbrooke (CHUS), where 95% of deliveries in the Eastern Townships occur and where nearly 100% of pediatric beds for acute care in the region are held. 4 Therefore, the vast majority of children living in the Eastern Townships requiring hospitalization for AGE attend the CHUS.
Data sources
Data on all births and hospitalizations occurring at the CHUS were obtained from CIRESSS (Centre informatisé de recherche évaluative en services et soins de santé), which is a local data warehouse based at the CHUS that has contained exhaustive data since 1991. Vaccination data were obtained from LOGIVAC, an immunization registry unique to the Eastern Townships in which all births in the region and all vaccines administered to the residents have been recorded since 1998, even for those born outside the region. Thus, all children born in the region, regardless of their vaccination status, are included in LOGIVAC. 15 Both primary and secondary diagnoses were considered, and two hospitalizations for the same infant occurring in less than 14 days were considered as one event. Hospitalizations rates were calculated by dividing the number of hospitalizations that occurred among children aged less than five years by the total number of children of the same age group in the birth cohort over a specified period. LOGIVAC provided information about rotavirus vaccines, including name, date of administration and number of doses received. Coverage was first calculated at the age of three months to assess the coverage of ≥1 dose of rotavirus vaccine since the approval of the two vaccines in 2006 and 2007. Coverage of eligible infants in the funded vaccination program was also assessed at the end of the period study, on May 31, 2014. Coverage was defined as the receipt of ≥1 dose among children born between August 1, 2011 and February 28, 2014 (aged between 3 and 33 months).
Study population
Individual Covariates
Several covariates were available in the CIRESSS database. Birth date allowed age to be calculated at the end of each "rotavirus" year (i.e., May 31), and this was then used to determine the denominators of age-specific hospitalization and vaccine coverage rates (<1, 1-2 and 3-4 years). Birth characteristics (all dichotomized) were sex, maternal age at birth (<25 vs. ≥25 years), gestational age at birth (<37 weeks [preterm infant] vs. ≥37 weeks [term infant]) and birth weight (<2500 g [low birth weight] vs. ≥2500 g [normal birth weight]). Place of residence, defined as eastern, central (i.e., Sherbrooke city) and western territories, was determined by the municipality of residence at birth.
Ecological Covariates
The population density (i.e., number of people per square kilometre), the rate of low-income families (i.e., families having an annual income below the low-income cut-off), the unemployment rate among people ≥25 years, the rate of single mothers (i.e., not living with a partner) and the proportion of mothers without a high school diploma (i.e., <11 school years completed), derived from the National Census (2006) and the Live Births File (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) , were measured at the dissemination area (DA) level. DA is the smallest geostatistical unit available from the census (approximately 400-700 persons by DA). 16 The six-digit residential postal codes at birth, provided by CIRESSS, were geocoded in order to assign a DA to each participant (total of 519 DAs), allowing pairing of the five ecological variables to respective children. These ecological variables were then categorized into tertiles (T1, T2, T3), T3 representing the highest rate or proportion of poor socio-economic indicators. In the absence of individual measures, these neighbourhood-level variables were used as proxy measures for the socio-economic status of participants, T1, T2 and T3 representing advantaged, middle and disadvantaged socioeconomic groups.
Statistical analyses
Monthly and annual AGE and RVGE hospitalization rates were examined to observe rotavirus seasonal patterns and long-term trends between June 2004 and May 2014. For further analyses, the focus was on AGE hospitalizations, which were considered to be more appropriate for assessing the overall trends in severe rotavirus infections, since laboratory-confirmed RVGE is less sensitive and may underestimate the rotavirus infections burden. 17 Focusing on AGE rather than RVGE also increased the statistical power to detect differences between subgroups. To compute the relative reduction in hospitalization rates between pre-and post-program periods, the mean annual AGE hospitalization rates were Mean annual hospitalization and vaccine coverage rates were calculated overall and according to demographic and socio-economic characteristics measured at individual and ecological levels. Children with missing variables were excluded only in the specific analyses involving those variables. Statistical comparisons of rates within subgroups in each study period were made using the chi-square test with significance level set at 0.05 (two-sided). Data were analyzed using SPSS. The research project was approved by the CHUS Ethics Committee.
RESULTS
Ten-year trends in hospitalization rates and vaccine coverage
In the cohort of 37,757 newborns, 882 hospitalizations for AGE were observed before the age of five years between June 2004 and May 2014. During the pre-program years, AGE hospitalization rates were characterized by a sharp increase between January and May ( Figure 1) . A similar seasonal pattern was observed for RVGE hospitalizations. In post-program years, AGE and RVGE hospitalization rates significantly decreased, particularly in the last year under investigation (2013/2014). The mean peaks of AGE and RVGE hospitalizations, observed in April for the pre-program period, were both dramatically flattened during the post-program period (Figures 2A and 2B) . Furthermore, monthly vaccine coverage of ≥1 dose was very low before the arrival of the rotavirus vaccination program, ranging from 0% to 4%. Soon after the program implementation, vaccine uptake increased markedly and was maintained during the following years to an average of 81% (Figure 1 ).
Pre-and post-program AGE hospitalization trends
In the whole cohort of newborns, annual AGE hospitalization rates significantly decreased from 81/10,000 in the pre-program period to 46/10,000 in the post-program period, representing an overall relative reduction of 43% (95% confidence interval [CI]: 33-51) (Table 1) . Less than 2% of children had missing information regarding sex, maternal age at birth or postal code. For all individual-level variables examined, each subgroup showed a decline in hospitalization rates during the post-program years in comparison with the pre-program years. However, lower relative and non-significant reductions were observed in specified subgroups, including children aged three and four years, children having a young mother and preterm children (26%, 19%, and 26% respectively). Regarding DA-level characteristics, all socioeconomic strata showed a significant relative reduction in the post-program period (Table 2) . However, the lowest relative reductions were generally observed among the most urban and the most socio-economically disadvantaged areas (T3). Indeed, children from densest DAs (T3) had a 27% reduction in hospitalization rates, whereas those living in DAs with low (T1) and medium (T2) population density had a much greater reduction (47% and 53% respectively). In the same vein, hospitalization rates declined less sharply in DAs with higher unemployment rates, higher low-income family rates and higher single mother rates (relative reductions of 35%, 26% and 30% respectively) than more advantaged DAs. It is noteworthy that some of the observed differences in AGE hospitalization rates among subgroups in postprogram years were not present in pre-program years.
Post-program vaccine coverage
In post-program years, coverage of ≥1 dose for all infants eligible for free vaccination was 81% (Table 1) . RV1 was the vaccine administered to 99.9% of these cases. Coverage in each socioeconomic subgroup ranged from 75% to 85%. Regarding individual characteristics, infants aged <1 year at admission, children having a young mother, normal birth weight children and those living in Sherbrooke were among the most frequently vaccinated. No significant differences were observed between DA-level subgroups.
DISCUSSION
This longitudinal study based on a large birth cohort was the first to examine the simultaneous evolution over the last decade of gastroenteritis hospitalization and rotavirus vaccine coverage rates among young children, overall and according to various socioeconomic characteristics. The substantial decline in AGE and RVGE pediatric hospitalizations in post-program years is consistent with that observed in previous impact studies conducted in industrialized countries, where a sustained reduction has been observed since the beginning of the rotavirus vaccination program.
18-21
Reductions over three consecutive years simultaneously occurring with the rapid increase in vaccine coverage indicates that these changes are likely due to the new rotavirus vaccination program. However, an important reduction in hospitalizations for gastroenteritis was also observed in 2009-2010, before the implementation of the program. This unexpected decline could possibly be explained by the natural fluctuation in rotavirus activity related to different rotavirus strains 22 or by the increase in general hygiene measures following the 2009 H1N1 influenza pandemic. Indeed, the 2010 weak rotavirus season was preceded by a strong rotavirus season in 2009, reflecting the biennial seasonal pattern of rotavirus. 23 The observed vaccine coverage of ≥1 dose in 81% of children aged 3-33 months during the post-program period is consistent with estimates from a recent survey conducted in children of one and two years old in Quebec (81%-88% for ≥1 dose) as well as with reported coverage among children aged 0-2 years in the Eastern Townships on the basis of LOGIVAC data (75% for 2 doses). 24, 25 The estimated coverage in the present study is slightly higher because coverage of ≥1 dose was assessed instead of a full series and possibly because our birth cohort did not include children born in birthing centres or at home. Indeed, a previous study found an association between assisted delivery by a midwife and incomplete immunization status (i.e., not all the recommended vaccines received). 26 Among children younger than five years, AGE hospitalization rates were significantly reduced in the post-program period (43%). This reduction corresponds to that observed in many studies in industrialized countries, ranging from 30% to 60%. [9] [10] [11] [18] [19] [20] [21] However, our study went further than previous studies by examining these trends according to several individual-and neighbourhood-level characteristics. As expected, children less than three years, who were eligible to receive the funded rotavirus vaccine, had the highest reductions, suggesting that the observed decline in gastroenteritis hospitalizations was due to rotavirus vaccine. Interestingly, children aged three and four years, too old to receive the rotavirus vaccine, still had a relative reduction of 26%. Although it did not reach statistical significance, this observation suggests a herd immunity effect of the vaccine, also observed in many other studies. [18] [19] [20] [21] Children living in Sherbrooke, which is the most central and most populous city, as well as those living in the densest DAs, had the lowest reductions in AGE hospitalization rates in comparison with children living in more rural areas. Urban clusters with high population density could increase the potential for transmission of rotavirus or other gastrointestinal pathogens, explaining the lower reduction in AGE hospitalizations in urban areas despite high vaccine coverage. For socio-economic ecological-level variables, the most disadvantaged subgroups generally showed the lowest rate reductions in post-program years. This may have been caused by factors other than vaccination itself as no significant difference in vaccine coverage according to socio-economic subgroups was observed in the present study. Indeed, people with low socioeconomic status generally differ from more well-off ones according to their living conditions (e.g., household crowding), their physical health (e.g., weaker immune status, smoking habits), their nutritional status and their health seeking behaviour. 27 A study from southern Israel showed similar results to ours in two distinct populations, and the authors suggested that the differential reduction could be partially explained by socio-economic conditions. 28 Moreover, because disadvantaged parents generally have fewer resources and may be less knowledgeable about the causes and cures of symptoms, 27 doctors tend to hospitalize these children more in order to achieve recovery. In Quebec, this practice was previously observed among asthmatic children, as those whose 
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fathers held economically disadvantaged occupations were more likely to be hospitalized. 29 This differential management from doctors may be a complementary hypothesis for the lower reduction in AGE hospitalizations observed in disadvantaged subgroups. This study had some limitations. Temporal trends could have been influenced by factors other than vaccination, such as natural variation in rotavirus activity and testing practices. However, the observed rate reductions were sustained over three consecutive years, suggesting that declines were most likely attributable to the vaccination program. For trends in RVGE hospitalizations, laboratory testing practices were probably similar over the study period, as the proportion of requests among hospitalized children was equivalent in pre-and post-program periods (data not shown). Concerning CIRESSS and LOGIVAC, both databases had no information about whether a child had moved out of the Eastern Townships after birth. This had the potential effect of underestimating gastroenteritis hospitalizations and vaccine coverage. However, this bias was presumably non-differential according to the birth and family characteristics or the outcomes examined, and did not preclude comparison of rates between preand post-program periods. Finally, the socio-economic status of parents was not available in both databases, but several proxies, measured at the finest ecological level available, were used to obtain the socio-economic level of the child's neighbourhood.
CONCLUSIONS
This impact study strongly suggests that the publicly funded rotavirus vaccination program significantly reduced gastroenteritis hospitalizations in young children. Moreover, Quebec's universal vaccination program demonstrated equitable access to rotavirus vaccine among different socio-economic subgroups. However, disadvantaged subgroups experienced a less pronounced AGE reduction, suggesting that factors other than vaccination may influence part of the reduction in hospitalization for gastroenteritis among young children. Based on the present study, a forthcoming study will assess vaccine effectiveness directly among children eligible for the rotavirus vaccination program, overall and according to socio-economic characteristics, to further explore the present findings.
